Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed signal to evaluate whether AI platforms. Aclarion Inc. is based in SAN MATEO, CA.
| Revenue (Most Recent Fiscal Year) | $0.08M |
| Net Income (Most Recent Fiscal Year) | $-7.23M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 110.17 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.44 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -10321.80% |
| Net Margin (Trailing 12 Months) | -10320.51% |
| Return on Equity (Trailing 12 Months) | -54.41% |
| Return on Assets (Trailing 12 Months) | -51.71% |
| Current Ratio (Most Recent Fiscal Quarter) | 19.65 |
| Quick Ratio (Most Recent Fiscal Quarter) | 19.65 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $15.02 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-1.34 |
| Earnings per Share (Most Recent Fiscal Year) | $-13.61 |
| Diluted Earnings per Share (Trailing 12 Months) | $-9.03 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Common Shares Outstanding | 2.46M |
| Free Float | 2.46M |
| Market Capitalization | $8.59M |
| Average Volume (Last 20 Days) | 0.08M |
| Beta (Past 60 Months) | 1.22 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.01% |
| Percentage Held By Institutions (Latest 13F Reports) | 7.52% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |